Drugmaker Files Ch. 11, Blames Low-Selling Urination Drug
Specialty drugmaker Avadel Specialty Pharmaceuticals filed for Chapter 11 in Delaware bankruptcy court Wednesday, saying slow sales growth for its nighttime urination drug caused its parent company to cut off funding...To view the full article, register now.
Already a subscriber? Click here to view full article